Our Technology | AI-Powered Cancer Detection
Smart, Accurate,
& Dynamic
Our AI Learns about Your Cells Fast
In addition to three dimensional images of your cells, our technology has the ability to learn and adapt to discover which cells should raise a red flag of warning and which are completely normal in your body.
LuCED® Clinical Performance
High resolution 3D cellular imaging combined with highly accurate AI classification of cells translates to outstanding clinical performance with high sensitivity detection of early-stage lung cancer at high specificity.
- Cancer Cytopathology (2015): Sensitivity = 92%, Specificity = 95%
- WCLC (2016): Sensitivity = 90% (N=79), Specificity* = 97% (N=60)
Looking towards
the Future
We have the potential to help other cancer concerns in addition to early detection of lung cancer.
Looking beyond the power to detect early lung cancer, our technology has the capability to see beyond and potentially identify lung dysplasia and opportunities to help those with high risk of bladder, esophageal, breast, pancreas and liver cancer.